Bilateral optic neuropathy associated with Castleman disease
Darier sign and cutaneous involvement in mastocytosis
Mucosal barrier injury, fever and infection in neutropenic patients with cancer: introducing the paradigm febrile mucositis
The diagnosis and management of von Willebrand disease: a United Kingdom Haemophilia Centre Doctors Organization guideline approved by the British Committee for Standards in Haematology
A randomized, open-label, multicentre, phase 2/3 study to evaluate the safety and efficacy of lumiliximab in combination with fludarabine, cyclophosphamide and rituximab versus fludarabine, cyclophosphamide and rituximab alone in subjects with relapsed chronic lymphocytic leukaemia
Persistence of DNMT3A mutations at long-term remission in adult patients with AML
Targeted therapy with MXD3 siRNA, anti-CD22 antibody and nanoparticles for precursor B-cell acute lymphoblastic leukaemia
Quantification of clonal circulating plasma cells in relapsed multiple myeloma
MYD88 L265P mutation contributes to the diagnosis of Bing Neel syndrome
The oncogenic JUNB/CD30 axis contributes to cell cycle deregulation in ALK+ anaplastic large cell lymphoma
L-Leucine improves the anaemia in models of Diamond Blackfan anaemia and the 5q- syndrome in a TP53-independent way
Storage and secretion of naturally occurring von Willebrand factor A domain variants
A lower intensity of treatment may underlie the increased risk of thrombosis in young patients with masked polycythaemia vera
Influence of proton pump inhibitors and VKORC1 mutations on CYP2C9-mediated dose requirements of vitamin K antagonist therapy: a pilot study
Next-generation sequencing is a credible strategy for blood group genotyping
Long-term survival with cyclophosphamide, bortezomib and dexamethasone induction therapy in patients with newly diagnosed multiple myeloma
Assessment of TP53 functionality in chronic lymphocytic leukaemia by different assays; an ERIC-wide approach
Progressive multifocal leukoencephalopathy as the presenting feature of chronic lymphocytic leukaemia
Sirolimus for the treatment of multi-resistant autoimmune haemolytic anaemia in children
Expression of tumour necrosis factor-α and its receptors in Hodgkin lymphoma
Central nervous system prophylaxis in patients with diffuse large B cell lymphoma, are we treating ourselves? A response to the recent BCSH Guideline
Central nervous system prophylaxis in patients with diffuse large B cell lymphoma, are we treating ourselves? A response to the recent BCSH Guideline – response to Griffin et al
The impact of anaemia on functioning in older people in a rural population in South West Uganda
Erratum